Phenotypic and Functional Responses of Human Decidua Basalis Mesenchymal Stem/Stromal Cells to Lipopolysaccharide of Gram-Negative Bacteria

References

• Shin JH, Ryu CM, Yu HY, Shin DM, Choo MS. Current and future directions of stem cell therapy for bladder dysfunction. Stem Cell Rev Rep. 2020;16(1):82–93.
   Web of Science ®Google Scholar
• Bae SH. Recent achievements in stem cell therapy for pediatric gastrointestinal tract disease. Pediatr Gastroenterol Hepatol Nutr. 2013;16(1):10–16. doi:10.5223/pghn.2013.16.1.10
   PubMedGoogle Scholar
• Quante M, Wang TC. Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol. 2009;6(12):724. doi:10.1038/nrgastro.2009.195
   PubMed Web of Science ®Google Scholar
• Van Der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–260. doi:10.1146/annurev.physiol.010908.163145
   PubMed Web of Science ®Google Scholar
• Ratajczak M, Suszynskan M, Pedziwiatr D, Mierzejewska K, Greco N. Umbilical cord blood-derived very small embryonic like stem cells (VSELs) as a source of pluripotent stem cells for regenerative medicine. Pediatr Endocrinol Rev. 2012;9(3):639–643.
   PubMedGoogle Scholar
• Chu DT, Nguyen TT, Tien NLB, et al. Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications. Cells. 2020;9(3):563. doi:10.3390/cells9030563
   PubMed Web of Science ®Google Scholar
• Ghafarzadeh M, Namdari P, Tarhani M, Tarhani F. A review of application of stem cell therapy in the management of Congenital Heart Disease. J Matern Fetal Neonatal Med. 2020;33(9):1607–1615.
   PubMed Web of Science ®Google Scholar
• Heo JS, Choi Y, Kim HS, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2015;37:115–125. doi:10.3892/ijmm.2015.2413
   Web of Science ®Google Scholar
• Elahi KC, Klein G, Avci-Adali M, Sievert KD, Macneil S, Aicher WK. Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns. Stem Cells Int. 2016;2016:1–9. doi:10.1155/2016/5646384
   Web of Science ®Google Scholar
• Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A systemic review of adult mesenchymal stem cell sources and their multilineage differentiation potential relevant to musculoskeletal tissue repair and regeneration. Curr Stem Cell Res. 2017;12:601–610.
   Web of Science ®Google Scholar
• Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol. 2002;283(1):R7–R28. doi:10.1152/ajpregu.00738.2001
   Web of Science ®Google Scholar
• Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204–1219. doi:10.1161/CIRCRESAHA.108.176826
   PubMed Web of Science ®Google Scholar
• Meirelles LDS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–2213. doi:10.1242/jcs.02932
   PubMed Web of Science ®Google Scholar
• Chen K, Wang D, Du WT, et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol. 2010;135:448–458. doi:10.1016/j.clim.2010.01.015
   Web of Science ®Google Scholar
• Nitzsche F, Müller C, Lukomska B, Jolkkonen J, Deten A, Boltze J. Concise review: MSC adhesion cascade—insights into homing and transendothelial migration. Stem Cells. 2017;35:1446–1460. doi:10.1002/stem.2614
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of Guinea pig bone marrow and spleen cells. Cell Prolif. 1970;3:393–403. doi:10.1111/j.1365-2184.1970.tb00347.x
   Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116(5):639–648. doi:10.1016/S0092-8674(04)00208-9
   PubMed Web of Science ®Google Scholar
• Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35–42. doi:10.1038/nm.3028
   PubMed Web of Science ®Google Scholar
• Abomaray FM, Al Jumah MA, Alsaad KO, et al. Phenotypic and functional characterization of mesenchymal stem/multipotent stromal cells from decidua basalis of human term placenta. Stem Cells Int. 2016;2016:1–18. doi:10.1155/2016/5184601
   Web of Science ®Google Scholar
• Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5–14. doi:10.3727/096368910X
   PubMed Web of Science ®Google Scholar
• Huang YC, Yang ZM, Chen XH, et al. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. 2009;5:247–255. doi:10.1007/s12015-009-9069-x
   Web of Science ®Google Scholar
• Kusuma GD, Abumaree MH, Pertile MD, Perkins AV, Brennecke SP, Kalionis B. Mesenchymal stem/stromal cells derived from a reproductive tissue niche under oxidative stress have high aldehyde dehydrogenase activity. Stem Cell Rev Rep. 2016;12(3):285–297. doi:10.1007/s12015-016-9649-5
   Web of Science ®Google Scholar
• Alshabibi MA, Khatlani T, Abomaray FM, et al. Human decidua basalis mesenchymal stem/stromal cells protect endothelial cell functions from oxidative stress induced by hydrogen peroxide and monocytes. Stem Cell Res Ther. 2018;9(1). doi:10.1186/s13287-018-1021-z
   Web of Science ®Google Scholar
• Khatlani T, Algudiri D, Alenzi R, et al. Preconditioning by hydrogen peroxide enhances multiple properties of human decidua basalis mesenchymal stem/multipotent stromal cells. Stem Cells Int. 2018;2018:1–13. doi:10.1155/2018/6480793
   Web of Science ®Google Scholar
• Alshabibi MA, Al Huqail AJ, Khatlani T, et al. Mesenchymal stem/multipotent stromal cells from human decidua basalis reduce endothelial cell activation. Stem Cells Dev. 2017;26:1355–1373. doi:10.1089/scd.2017.0096
   Web of Science ®Google Scholar
• De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol. 2001;6:30–40. doi:10.1902/annals.2001.6.1.30
   PubMedGoogle Scholar
• Kuramitsu HK, Kang IC, Qi M. Interactions of Porphyromonas gingivalis with host cells: implications for cardiovascular diseases. J Periodontol. 2003;74:85–89. doi:10.1902/jop.2003.74.1.85
   Web of Science ®Google Scholar
• Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002;105:861–867. doi:10.1161/hc0702.104178
   PubMed Web of Science ®Google Scholar
• Horseman MA, Surani S, Bowman JD. Endotoxin, toll-like receptor-4, and atherosclerotic heart disease. Curr Cardiol Rev. 2017;13(2):81–93.
   Web of Science ®Google Scholar
• Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003;67:593–656.
   PubMed Web of Science ®Google Scholar
• Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217–225. doi:10.1096/fasebj.8.2.8119492
   PubMed Web of Science ®Google Scholar
• Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002;71:635–700. doi:10.1146/annurev.biochem.71.110601.135414
   PubMed Web of Science ®Google Scholar
• Goto T, Eden S, Nordenstam G, Sundh V, Svanborg-Eden C, Mattsby-Baltzer I. Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol. 1994;1:684–688. doi:10.1128/cdli.1.6.684-688.1994
   PubMedGoogle Scholar
• Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838–1842. doi:10.1016/S0140-6736(98)09286-1
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ, Kiechl S, Dunzendorfer S, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999;34:1975–1981. doi:10.1016/S0735-1097(99)00448-9
   PubMed Web of Science ®Google Scholar
• Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation. 2001;103(8):1064–1070. doi:10.1161/01.CIR.103.8.1064
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491
   PubMed Web of Science ®Google Scholar
• Applebaum KM, Ray RM, Astrakianakis G. Evidence of a paradoxical relationship between endotoxin and lung cancer after accounting for left truncation in a study of Chinese female textile workers. Occup Environ Med. 2013;70(10):709–715. doi:10.1136/oemed-2012-101240
   Web of Science ®Google Scholar
• Jeon D, Kim SJ, Kim HS. Anti-inflammatory evaluation of the methanolic extract of Taraxacum officinale in LPS-stimulated human umbilical vein endothelial cells. BMC Complement Altern Med. 2017;17(1). doi:10.1186/s12906-017-2022-7
   Web of Science ®Google Scholar
• Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340(2):115–126. doi:10.1056/NEJM199901143400207
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. doi:10.1161/ATVBAHA.108.179705
   PubMed Web of Science ®Google Scholar
• Pfeffer R, Ganatos P, Nir A, Weinbaum S. Diffusion of macromolecules across the arterial wall in the presence of multiple endothelial injuries. J Biomech Eng. 1981;103:197–203. doi:10.1115/1.3138278
   PubMed Web of Science ®Google Scholar
• Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:2227–2236. doi:10.1161/01.ATV.0000147534.69062.dc
   PubMed Web of Science ®Google Scholar
• Weinbaum S, Tzeghai G, Ganatos P, Pfeffer R, Chien S. Effect of cell turnover and leaky junctions on arterial macromolecular transport. Am J Physiol. 1985;248:H945–960.
   PubMed Web of Science ®Google Scholar
• Lehr HA, Sagban TA, Ihling C, et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001;104:914–920. doi:10.1161/hc3401.093153
   PubMed Web of Science ®Google Scholar
• Ostos MA, Recalde D, Zakin MM, Scott-Algara D. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett. 2002;519:23–29. doi:10.1016/S0014-5793(02)02692-3
   Web of Science ®Google Scholar
• Rice JB, Stoll LL, Li WG, et al. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol. 2003;23:1576–1582. doi:10.1161/01.ATV.0000081741.38087.F9
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr. 2010;91(4):940–949. doi:10.3945/ajcn.2009.28584
   PubMed Web of Science ®Google Scholar
• Laugerette FC, Vors A, Geloen A. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem. 2011;22(1):53–59. doi:10.1016/j.jnutbio.2009.11.011
   PubMed Web of Science ®Google Scholar
• Abumaree MH, Abomaray FM, Alshabibi MA, AlAskar AS, Kalionis B. Immunomodulatory properties of human placental mesenchymal stem/ stromal cells. Placenta. 2017;59:87–95. doi:10.1016/j.placenta.2017.04.003
   PubMed Web of Science ®Google Scholar
• Abumaree MH, Hakami M, Abomaray FM, et al. Human chorionic villous mesenchymal stem/stromal cells modify the effects of oxidative stress on endothelial cell functions. Placenta. 2017;59:74–86. doi:10.1016/j.placenta.2017.05.001
   Web of Science ®Google Scholar
• Basmaeil YS, Al Subayyil AM, Khatlani T, et al. Human chorionic villous mesenchymal stem/stromal cells protect endothelial cells from injury induced by high level of glucose. Stem Cell Res Ther. 2018;9:238. doi:10.1186/s13287-018-0984-0
   Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–736. doi:10.1038/nri2395
   PubMed Web of Science ®Google Scholar
• Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34:747–754. doi:10.1038/aps.2013.50
   PubMed Web of Science ®Google Scholar
• Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25:829–848. doi:10.3727/096368915X689622
   PubMed Web of Science ®Google Scholar
• Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004;40(6):1275–1284. doi:10.1002/hep.20469
   PubMed Web of Science ®Google Scholar
• Paunescu V, Deak E, Herman D, Siska IR, Tanasie G, Bunu C. In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med. 2007;11:502–508. doi:10.1111/j.1582-4934.2007.00041.x
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci. 2009;106:14022–14027. doi:10.1073/pnas.0903201106
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381–390.
   PubMedGoogle Scholar
• Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells—current trends and future prospective. Biosci Rep. 2015;28:35.
   Google Scholar
• Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther. 2010;5:103–110. doi:10.2174/157488810791268564
   PubMed Web of Science ®Google Scholar
• Jimenez-Puerta GJ, Marchal JA, López-Ruiz E, Gálvez-Martín P. Role of mesenchymal stromal cells as therapeutic agents: potential mechanisms of action and implications in their clinical use. J Clin Med. 2020;9(2):445th ser. doi:10.3390/jcm9020445
   Web of Science ®Google Scholar
• Kot M, Musiał-Wysocka A, Lasota M, Ulman A, Majka M. Secretion, migration and adhesion as key processes in the therapeutic activity of mesenchymal stem cells. Acta Biochim Pol. 2019;66(4):499–507.
   Web of Science ®Google Scholar
• Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462–471. doi:10.1634/stemcells.2004-0331
   PubMed Web of Science ®Google Scholar
• Lee KA, Shim W, Paik MJ, et al. Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time. Cytotherapy. 2009;11(6):688–697. doi:10.3109/14653240902974032
   PubMed Web of Science ®Google Scholar
• Schoeberlein A, Mueller M, Reinhart U, Sager R, Messerli M, Surbek DV. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model. Am J Obstet Gynecol. 2011;205(277):e1–e6. doi:10.1016/j.ajog.2011.06.044
   Web of Science ®Google Scholar
• Fossett E, Khan W. Optimising human mesenchymal stem cell numbers for clinical application: a literature review. Stem Cells Int. 2012;2012:1–5. doi:10.1155/2012/465259
   Web of Science ®Google Scholar
• Francois S, Mouiseddine M, Allenet-Lepage B. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. Biomed Res Int. 2013;2013:1–14. doi:10.1155/2013/151679
   Web of Science ®Google Scholar
• Halabian R, Tehrani HA, Jahanian-Najafabadi A, Roudkenar MH. Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow derived mesenchymal stem cells against unfavorable microenvironments. Cell Stress Chaperones. 2013;18:785–800. doi:10.1007/s12192-013-0430-2
   PubMed Web of Science ®Google Scholar
• Han SM, Han SH, Coh YR. Enhanced proliferation and differentiation of Oct4-and Sox2-overexpressing hu man adipose tissue mesenchymal stem cells. Exp Mol Med. 2014;46:e101. doi:10.1038/emm.2014.28
   PubMed Web of Science ®Google Scholar
• Amiri F, Jahanian-Najafabadi A, Roudkenar MH. In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments. Cell Stress Chaperones. 2015;20:237–251. doi:10.1007/s12192-014-0560-1
   PubMed Web of Science ®Google Scholar
• Hagberg H, Mallard C, Ferriero DM. The role of inflammation in perinatal brain injury. Nat Rev Neurol. 2015;11:192. doi:10.1038/nrneurol.2015.13
   PubMed Web of Science ®Google Scholar
• Mueller M, Wolfs TG, Schoeberlein A, Gavilanes AW, Surbek D, Kramer BW. Mesenchymal stem/ stromal cells—a key mediator for regeneration after perinatal morbidity. Mol Cell Pediatr. 2016;3:6. doi:10.1186/s40348-016-0034-x
   Google Scholar
• Raijmakers MT, Roes EM, Poston L, Steegers EA, Peters WH. The transient increase of oxidative stress during normal pregnancy is higher and persists after delivery in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2008;138(1):39–44. doi:10.1016/j.ejogrb.2007.08.005
   Web of Science ®Google Scholar
• Ashok A, Nabil A, Botros R. Studies on Women’s Health: Oxidative Stress in Applied Basic Research and Clinical Practice. Agarwal A, Aziz N, Rizk B, editors. New York: Humana Press; 2013.
   Google Scholar
• Basmaeil Y, Rashid MA, Khatlani T, et al. Preconditioning of human decidua basalis mesenchymal stem/stromal cells with glucose increased their engraftment and anti-diabetic properties. Tissue Eng Regen Med. 2020;17(2):209.
   Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sci. 2011;88(1–2):65–73. doi:10.1016/j.lfs.2010.10.023
   PubMed Web of Science ®Google Scholar
• Lai P, Li T, Yang J, et al. Upregulation of stromal cell-derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury. Graefes Arch Clin Exp Ophthalmol. 2008;246(12):1707–1713. doi:10.1007/s00417-008-0907-3
   Web of Science ®Google Scholar
• Richmond A. Chemokine modulation of the tumor microenvironment. Pigment Cell Melanoma Res. 2010;23(3):312–313. doi:10.1111/j.1755-148X.2010.00714.x
   Web of Science ®Google Scholar
• Silva LHA, Antunes MA, Dos Santos CC, Weiss DJ, Cruz FF, Rocco PRM. Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases. Stem Cell Res Ther. 2018;9(1):45. doi:10.1186/s13287-018-0802-8
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu C, Han F, Cai F, Wang J, Chen J. Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation. Stem Cell Res Ther. 2020;11(1):197. doi:10.1186/s13287-020-01721-8
   PubMed Web of Science ®Google Scholar
• Kurte M, Vega-Letter AM, Luz-Crawford P, et al. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE. Stem Cell Res Ther. 2020;11(1). doi:10.1186/s13287-020-01840-2
   Web of Science ®Google Scholar
• Durand N, Russell A, Zubair AC. Effect of comedications and endotoxins on mesenchymal stem cell secretomes, migratory and immunomodulatory capacity. J Clin Med. 2019;8(4):497. doi:10.3390/jcm8040497
   PubMed Web of Science ®Google Scholar
• Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186:3283–3288. doi:10.4049/jimmunol.1003049
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu S, Hu R, Zhou Q, Li X. Decreased placental IL9 and IL9R in preeclampsia impair trophoblast cell proliferation, invasion, and angiogenesis. Hypertens Pregnancy. 2020;39(3):228–235.
   PubMed Web of Science ®Google Scholar
• Bigildeev AE, Zezina EA, Shipounova IN, Drize NJ. Interleukin-1 beta enhances human multipotent mesenchymal stromal cell proliferative potential and their ability to maintain hematopoietic precursor cells. Cytokine. 2015;71(2):246–254. doi:10.1016/j.cyto.2014.10.018
   Web of Science ®Google Scholar
• Matsumura E, Tsuji K, Komori K, Koga H, Sekiya I, Muneta T. Pretreatment with IL-1β enhances proliferation and chondrogenic potential of synovium-derived mesenchymal stem cells. Cytotherapy. 2017;19(2):181–193. doi:10.1016/j.jcyt.2016.11.004
   Web of Science ®Google Scholar
• Amann EM, Groß A, Rojewski MT, et al. Inflammatory response of mesenchymal stromal cells after in vivo exposure with selected trauma-related factors and polytrauma serum. PLoS One. 2019;14(5):e0216862. doi:10.1371/journal.pone.0216862
   Web of Science ®Google Scholar
• Cui TX, Brady AE, Fulton CT, et al. CCR2 mediates chronic LPS-induced pulmonary inflammation and hypoalveolarization in a murine model of bronchopulmonary dysplasia. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.579628
   Web of Science ®Google Scholar
• Wynn RF, Hart CA, Corradi-Perini C, O’Neill L, Evans CA, Wraith JE. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104:2643–2645. doi:10.1182/blood-2004-02-0526
   PubMed Web of Science ®Google Scholar
• Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106:419–427. doi:10.1182/blood-2004-09-3507
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2005;24:1030–1041. doi:10.1634/stemcells.2005-0319
   Web of Science ®Google Scholar
• Von Luttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, Seliger C. Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 2005;14:329–336. doi:10.1089/scd.2005.14.329
   PubMed Web of Science ®Google Scholar
• Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1. CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007;101:135–146. doi:10.1002/jcb.21172
   PubMed Web of Science ®Google Scholar
• Ma J, Liu N, Yi B, Zhang X, Gao BB, Zhang Y. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats. Neurol Res. 2015;37:50–56. doi:10.1179/1743132814Y.0000000399
   PubMed Web of Science ®Google Scholar
• Wobus M, List C, Dittrich T, Dhawan A, Duryagina R, Arabanian LS. Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12. Int J Cancer. 2014;136:44–54. doi:10.1002/ijc.28960
   Web of Science ®Google Scholar
• Shen Z, Wang J, Huang Q, et al. Genetic modification to induce CXCR2 overexpression in mesenchymal stem cells enhances treatment benefits in radiation-induced oral mucositis. Cell Death Dis. 2018;9(2). doi:10.1038/s41419-018-0310-x
   Web of Science ®Google Scholar
• Meirelles LDS, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20:419–427. doi:10.1016/j.cytogfr.2009.10.002
   PubMed Web of Science ®Google Scholar
• Escacena N, Quesada-Hernandez E, Capilla-Gonzalez V, Soria B, Hmadcha A. Bottlenecks in the efficient use of advanced therapy medicinal products based on mesenchymal stromal cells. Stem Cells Int. 2015;2015:895714.
   Web of Science ®Google Scholar
• Hmadcha A, Martin-Montalvo A, Gauthier BR, Soria B, Capilla-Gonzalez V. Therapeutic potential of mesenchymal stem cells for cancer therapy. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.00043
   Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–3843. doi:10.1182/blood.V99.10.3838
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol. 2006;177:2080–2087. doi:10.4049/jimmunol.177.4.2080
   PubMed Web of Science ®Google Scholar
• Nemeth K, Keane-Myers A, Brown JM, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci. 2010;107:5652–5657. doi:10.1073/pnas.0910720107
   PubMed Web of Science ®Google Scholar
• Du-Rocher B, Binato R, de-freitas-junior JCM, et al. IL-17 triggers invasive and migratory properties in human MSCs, while IFNγ favors their immunosuppressive capabilities: implications for the “licensing” process. Stem Cell Rev Rep. 2020;16(6):1266–1279. doi:10.1007/s12015-020-10051-4
   Web of Science ®Google Scholar
• Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol. 1999;162(1):494–502.
   PubMed Web of Science ®Google Scholar
• Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferon-γ are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119(10):1424–1432. doi:10.1161/CIRCULATIONAHA.108.827618
   PubMed Web of Science ®Google Scholar
• Bulek K, Liu C, Swaidani S, et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol. 2011;12(9):844–852. doi:10.1038/ni.2080
   PubMed Web of Science ®Google Scholar
• Gabr MA, Jing L, Helbling AR, et al. Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res. 2011;29(1):1–7. doi:10.1002/jor.21206
   PubMed Web of Science ®Google Scholar
• Ekström K, Omar O, Granéli C, Wang X, Vazirisani F, Thomsen P. Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells. PLoS One. 2013;8(9):e75227. doi:10.1371/journal.pone.0075227
   Web of Science ®Google Scholar
• Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009;18(4):545–559. doi:10.1089/scd.2008.0130
   PubMed Web of Science ®Google Scholar
• Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272–288. doi:10.7150/ijbs.2929
   PubMed Web of Science ®Google Scholar